Yahoo Web Search

Search results

    • Chemotherapy

      • One hundred years ago, Paul Ehrlich, the founder of chemotherapy, received the Nobel Prize for Physiology or Medicine. His postulate of creating 'magic bullets' for use in the fight against human diseases inspired generations of scientists to devise powerful molecular cancer therapeutics.
      www.nature.com › articles › nrc2394
  1. en.wikipedia.org › wiki › Paul_EhrlichPaul Ehrlich - Wikipedia

    Paul Ehrlich (German: [ˈpaʊl ˈʔeːɐ̯lɪç] ⓘ; 14 March 1854 – 20 August 1915) was a Nobel Prize-winning German physician and scientist who worked in the fields of hematology, immunology, and antimicrobial chemotherapy.

    • Stephanie and Marianne
    • Immunology
    • Hedwig Pinkus (1864–1948) (m. 1883; 2 children)
  2. Paul Ehrlich was a German medical scientist known for his pioneering work in hematology, immunology, and chemotherapy and for his discovery of the first effective treatment for syphilis. He received the Nobel Prize for Physiology or Medicine in 1908 jointly with Élie Metchnikoff.

  3. German biochemist Paul Ehrlich (1854–1915) developed a chemical theory to explain the body’s immune response and did important work in chemotherapy, coining the term magic bullet. Ehrlich received the Nobel Prize in Physiology or Medicine in 1908.

  4. Feb 5, 2016 · In 1878, he obtained his doctoral degree in medicine in Leipzig. Although trained as a physician, Paul Ehrlich was obsessed by laboratory work and dye staining of tissue samples and blood leukocytes [ 10, 11, 12, 13 ]. Paul Ehrlich's career can essentially be divided into three phases (table. .

    • Peter Valent, Bernd Groner, Udo Schumacher, Giulio Superti-Furga, Meinrad Busslinger, Robert Kralovi...
    • 10.1159/000443526
    • 2016
    • J Innate Immun. 2016 Mar; 8(2): 111-120.
  5. In 1878 he obtained his doctorate of medicine by means of a dissertation on the theory and practice of staining animal tissues. This work was one of the results of his great interest in the aniline dyes discovered by W. H. Perkin in 1853.

  6. Jan 25, 2024 · Based on his research, he is considered as the founder of chemotherapy, since he was the first scientist to develop targeted pharmaceutical treatment against syphilis using the organic arsenic-based compound, Salvarsan. In 1908, Paul Ehrlich received the Nobel Prize for Medicine in the field of immunology together with Ilia Metschnikow.

  7. Ehrlich's research career began with selective cell staining with dyes, which allowed him to identify mast cells and the different types of granulocytes. Such...

  1. People also search for